Verwandte Artikel zu Neoadjuvant Immunotherapy Treatment of Localized Genitourina...
Neoadjuvant Immunotherapy Treatment of Localized Genitourinary Cancers: Multidisciplinary Management - Hardcover
Inhaltsangabe
This book aims to provide readers with a current overview of enrolling trials with immune-checkpoint inhibitors in the preoperative setting of localized bladder cancer, renal cell carcinoma, and prostate cancer. The advent of immunotherapy has revolutionized treatments of genitourinary malignancy and evolved strategies for multidisciplinary management. This book explains neoadjuvant checkpoint inhibitors in localized genitourinary cancers, providing insights into the mechanisms of response and development of resistance of cancer cells to immunotherapy. It debates optimal trial design of preoperative checkpoint inhibitors in GU tumors, including optimal endpoints and the role of pathologic response as a surrogate endpoint of survival. It also illuminates clinical management of patients with organ-confined GU tumors, such as side effect management and perioperative safety, before providing an overview of biomarker use for patient selection across the early-stage GU malignancies. Lastly, the book provides the reader with the most up-to-date data emerging from clinical trials involving immunotherapy in early-stage GU malignancies.
Neoadjuvant Immunotherapy Treatment of Localized Genitourinary Cancers: Multidisciplinary Management provides a comprehensive review of the field, serving as a valuable resource for urologists, medical oncologists, pathologists, fellows in urologic oncology, upper-level residents training in urology and medical oncology, as well as pharmacists interested in RCC clinicians.
Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.
Über die Autorin bzw. den Autor
Andrea Necchi
Associate Professor, Vita-Salute San Raffaele UniversityHead of Genitourinary Medical OncologyIRCCS San Raffaele Hospital and Scientific InstituteVia Olgettina 60, 20132Milan, Italy
Philippe E. SpiessSenior Member, Department of GU OncologySenior Member, Department of Tumor BiologyAssistant Chief of Surgical ServicesMoffitt Cancer CenterProfessor, Department of UrologyUniversity of South FloridaTampa, FloridaUSA
Von der hinteren Coverseite
<div><div><div>This book aims to provide readers with a current overview of enrolling trials with immune-checkpoint inhibitors in the preoperative setting of localized bladder cancer, renal cell carcinoma, and prostate cancer. The advent of immunotherapy has revolutionized treatments of genitourinary malignancy and evolved strategies for multidisciplinary management. This book explains neoadjuvant checkpoint inhibitors in localized genitourinary cancers, providing insights into the mechanisms of response and development of resistance of cancer cells to immunotherapy. It debates optimal trial design of preoperative checkpoint inhibitors in GU tumors, including optimal endpoints and the role of pathologic response as a surrogate endpoint of survival. It also illuminates clinical management of patients with organ-confined GU tumors, such as side effect management and perioperative safety, before providing an overview of biomarker use for patient selection across the early-stage GU malignancies. Lastly, the book provides the reader with the most up-to-date data emerging from clinical trials involving immunotherapy in early-stage GU malignancies. </div><div><br></div><div><i>Neoadjuvant Immunotherapy Treatment of Localized Genitourinary Cancers: Multidisciplinary Management</i> provides a comprehensive review of the field, serving as a valuable resource for urologists, medical oncologists, pathologists, fellows in urologic oncology, upper-level residents training in urology and medical oncology, as well as pharmacists interested in RCC clinicians.</div></div><div><br></div></div>
„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.
- VerlagSpringer-Verlag GmbH
- Erscheinungsdatum2022
- ISBN 10 303080545X
- ISBN 13 9783030805456
- EinbandTapa dura
- SpracheEnglisch
- Auflage1
- Anzahl der Seiten336
- HerausgeberSpiess Philippe E., Necchi Andrea
Neu kaufen
Diesen Artikel anzeigen
EUR 160,49
Gratis für den Versand innerhalb von/der Deutschland
Versandziele, Kosten & Dauer
Suchergebnisse für Neoadjuvant Immunotherapy Treatment of Localized Genitourina...
Beispielbild für diese ISBN
Neoadjuvant Immunotherapy Treatment of Localized Genitourinary Cancers : Multidisciplinary Management
Verlag:
Springer International Publishing, 2022
ISBN 10: 303080545X
ISBN 13: 9783030805456
Gebraucht
Hardcover
Anbieter: Buchpark, Trebbin, Deutschland
Verkäuferbewertung 5 von 5 Sternen
Zustand: Hervorragend. Zustand: Hervorragend | Seiten: 336 | Sprache: Englisch | Produktart: Bücher. Artikel-Nr. 38404178/1
Anzahl: 1 verfügbar
Foto des Verkäufers
Neoadjuvant Immunotherapy Treatment of Localized Genitourinary Cancers : Multidisciplinary Management
Verlag:
Springer International Publishing, 2022
ISBN 10: 303080545X
ISBN 13: 9783030805456
Neu
Hardcover
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Verkäuferbewertung 5 von 5 Sternen
Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book aims to provide readers with a current overview of enrolling trials with immune-checkpoint inhibitors in the preoperative setting of localized bladder cancer, renal cell carcinoma, and prostate cancer. The advent of immunotherapy has revolutionized treatments of genitourinary malignancy and evolved strategies for multidisciplinary management. This book explains neoadjuvant checkpoint inhibitors in localized genitourinary cancers, providing insights into the mechanisms of response and development of resistance of cancer cells to immunotherapy. It debates optimal trial design of preoperative checkpoint inhibitors in GU tumors, including optimal endpoints and the role of pathologic response as a surrogate endpoint of survival. It also illuminates clinical management of patients with organ-confined GU tumors, such as side effect management and perioperative safety, before providing an overview of biomarker use for patient selection across the early-stage GU malignancies.Lastly, the book provides the reader with the most up-to-date data emerging from clinical trials involving immunotherapy in early-stage GU malignancies.Neoadjuvant Immunotherapy Treatment of Localized Genitourinary Cancers: Multidisciplinary Management provides a comprehensive review of the field, serving as a valuable resource for urologists, medical oncologists, pathologists, fellows in urologic oncology, upper-level residents training in urology and medical oncology, as well as pharmacists interested in RCC clinicians. Artikel-Nr. 9783030805456
Anzahl: 1 verfügbar